298 related articles for article (PubMed ID: 23909966)
1. Changes in Mini-Mental State Examination score in Alzheimer's disease patients after stopping habitual drinking.
Toda A; Tagata Y; Nakada T; Komatsu M; Shibata N; Arai H
Psychogeriatrics; 2013 Jun; 13(2):94-8. PubMed ID: 23909966
[TBL] [Abstract][Full Text] [Related]
2. Item analysis of ADAS-Cog: effect of baseline cognitive impairment in a clinical AD trial.
Sevigny JJ; Peng Y; Liu L; Lines CR
Am J Alzheimers Dis Other Demen; 2010 Mar; 25(2):119-24. PubMed ID: 19949163
[TBL] [Abstract][Full Text] [Related]
3. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
4. Stem cell factor plasma levels are decreased in Alzheimer's disease patients with fast cognitive decline after one-year follow-up period: the Pythia-study.
Laske C; Sopova K; Hoffmann N; Stransky E; Hagen K; Fallgatter AJ; Stellos K; Leyhe T
J Alzheimers Dis; 2011; 26(1):39-45. PubMed ID: 21593573
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
[TBL] [Abstract][Full Text] [Related]
6. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.
Smits LL; Pijnenburg YA; Koedam EL; van der Vlies AE; Reuling IE; Koene T; Teunissen CE; Scheltens P; van der Flier WM
J Alzheimers Dis; 2012; 30(1):101-8. PubMed ID: 22366769
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and cognitive impact of cerebrovascular findings in Alzheimer's disease: a retrospective, naturalistic study.
Tabet N; Quinn R; Klugman A
Int J Clin Pract; 2009 Feb; 63(2):338-45. PubMed ID: 19196375
[TBL] [Abstract][Full Text] [Related]
8. The effect of HMG-CoA reductase inhibitors on cognition in patients with Alzheimer's dementia: a prospective withdrawal and rechallenge pilot study.
Padala KP; Padala PR; McNeilly DP; Geske JA; Sullivan DH; Potter JF
Am J Geriatr Pharmacother; 2012 Oct; 10(5):296-302. PubMed ID: 22921881
[TBL] [Abstract][Full Text] [Related]
9. Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: a retrospective study.
Caballero J; Hitchcock M; Scharre D; Beversdorf D; Nahata MC
Clin Ther; 2006 Oct; 28(10):1695-700. PubMed ID: 17157125
[TBL] [Abstract][Full Text] [Related]
10. Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
Velayudhan L; Proitsi P; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Hodges A; Powell J; Lovestone S; Simmons A;
J Alzheimers Dis; 2013; 33(3):755-66. PubMed ID: 23047370
[TBL] [Abstract][Full Text] [Related]
11. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM
Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933
[TBL] [Abstract][Full Text] [Related]
12. Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.
Palmer K; Lupo F; Perri R; Salamone G; Fadda L; Caltagirone C; Musicco M; Cravello L
J Alzheimers Dis; 2011; 24(1):35-45. PubMed ID: 21157019
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.
Suh GH; Ju YS; Yeon BK; Shah A
Int J Geriatr Psychiatry; 2004 Sep; 19(9):817-24. PubMed ID: 15352138
[TBL] [Abstract][Full Text] [Related]
14. Correlations among cognitive and behavioural assessments in patients with dementia due to Alzheimer's disease.
de Oliveira FF; Wajman JR; Bertolucci PH; Chen ES; Smith MC
Clin Neurol Neurosurg; 2015 Aug; 135():27-33. PubMed ID: 26010393
[TBL] [Abstract][Full Text] [Related]
15. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.
Harwood DG; Sultzer DL; Wheatley MV
Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):83-8. PubMed ID: 10780626
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for rapid loss on the mini-mental state examination in Alzheimer's disease.
Dumont C; Voisin T; Nourhashemi F; Andrieu S; Koning M; Vellas B
J Nutr Health Aging; 2005; 9(3):163-7. PubMed ID: 15864396
[TBL] [Abstract][Full Text] [Related]
17. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of galantamine on cognitive function in Alzheimer's disease: a large-scale international retrospective study.
Kavanagh S; Van Baelen B; Schäuble B
J Alzheimers Dis; 2011; 27(3):521-30. PubMed ID: 21891871
[TBL] [Abstract][Full Text] [Related]
19. Category verbal fluency predicted changes in behavioral and psychological symptoms of dementia in patients with Alzheimer's disease.
Tsai CF; Wang SJ; Zheng L; Fuh JL
Psychiatry Clin Neurosci; 2010 Aug; 64(4):408-14. PubMed ID: 20573053
[TBL] [Abstract][Full Text] [Related]
20. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
Benge JF; Balsis S; Geraci L; Massman PJ; Doody RS
Dement Geriatr Cogn Disord; 2009; 28(1):63-9. PubMed ID: 19641319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
